Skip to main content

Advertisement

SpringerLink
Log in

The epidemiology of hepatocellular carcinoma in hcv

  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) accounts for over 75% of all cases o f primary liver cancer in the world. It has predominantly affected persons in developing countries. In the United States, the incidence has traditionally reflected racial, ethnic, and regional variations. However, the incidence and mortality rates of HCC have been rising over the past two decades in the United States and western Europe. This increase has been positively associated with the increase in chronic hepatitis C virus (HCV) infection in these areas. This article discusses the epidemiology of HCC in the setting of HCV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. El-Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127:S27-S34. An excellent, up-to-date review of the trends of HCC in the U.S. Includes regional and temporal trends.

    Article  PubMed  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74–108.

    PubMed  Google Scholar 

  3. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745–750.

    Article  PubMed  CAS  Google Scholar 

  4. McGlynn KA, Tsao L, Hsing AW, et al.: International trends and patterns of primary liver cancer. Int J Cancer 2001, 94:290–296.

    Article  PubMed  CAS  Google Scholar 

  5. Velazquez RF, Rodriguez M, Navascues CA, et al.: Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003, 37:520–527.

    Article  PubMed  Google Scholar 

  6. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.

    Article  PubMed  Google Scholar 

  7. Sangiovanni A, Del Ninno E, Fasani P, et al.: Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004, 126:1005–1014.

    Article  PubMed  Google Scholar 

  8. Yuan JM, Govindarajan S, Arakawa K, Yu MC: Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004, 101:1009–1017.

    Article  PubMed  Google Scholar 

  9. Tanaka H, Tsukuma H, Kasahara A, et al.: Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. Int J Cancer 2000, 87:741–749.

    Article  PubMed  CAS  Google Scholar 

  10. Niederau C, Lange S, Heintges T, et al.: Prognosis of chronic hepatitis C: results of a large, prospective cohor t study. Hepatology 1998, 28:1687–1695.

    Article  PubMed  CAS  Google Scholar 

  11. Hamada H, Yatsuhashi H, Yano K, et al.: Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer 2002, 95:331–339.

    Article  PubMed  Google Scholar 

  12. Arase Y, Ikeda K, Tsubota A, et al.: Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection. Intervirology 2004, 47:355–361.

    Article  PubMed  CAS  Google Scholar 

  13. Sarbah SA, Gramlich T, Younoszai A, et al.: Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci 2004, 49:850–853.

    Article  PubMed  CAS  Google Scholar 

  14. Tanaka H, Tsukuma H, Yamano H, et al.: Prospective study on the risk of hepatocellular carcinoma among hepatitis C viruspositive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer 2004, 112:1075–1080.

    Article  PubMed  CAS  Google Scholar 

  15. Degos F, Christidis C, Ganne-Carrie N, et al.: Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000, 47:131–136.

    Article  PubMed  CAS  Google Scholar 

  16. Yoshida H, Shiratori Y, Moriyama M, et al.: Interferon therapy reduces the risk for hepatocellular car cinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 1999, 131:174–181.

    PubMed  CAS  Google Scholar 

  17. Gelatti U, Donato F, Tagger A, et al.: Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol 2003, 98:907–914.

    Article  PubMed  Google Scholar 

  18. Davila JA, Morgan RO, Shaib Y, et al.: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005, 54:533–539.

    Article  PubMed  CAS  Google Scholar 

  19. Hassan MM, Hwang LY, Hatten CJ, et al.: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206–1213.

    Article  PubMed  CAS  Google Scholar 

  20. La Vecchia C, Negri E, Decarli A, Franceschi S: Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997, 73:204–207.

    Article  PubMed  Google Scholar 

  21. Kirk GD, Lesi OA, Mendy M, et al.: The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004, 39:211–219.

    Article  PubMed  Google Scholar 

  22. Sun CA, Wu DM, Lin CC, et al.: Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 2003, 157:674–682.

    Article  PubMed  Google Scholar 

  23. Ohata K, Hamasaki K, Toriyama K, et al.: Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003, 97:3036–3043.

    Article  PubMed  Google Scholar 

  24. Aizawa Y, Shibamoto Y, Takagi I, et al.: Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer 2000, 89:53–59.

    Article  PubMed  CAS  Google Scholar 

  25. Kao JH, Chen DS: Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int 2005, 25:696–703.

    Article  PubMed  Google Scholar 

  26. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA: The continuing incr ease in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817–823.

    PubMed  Google Scholar 

  27. El-Serag HB, Mason AC: Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000, 160:3227–3230.

    Article  PubMed  CAS  Google Scholar 

  28. Hassan MM, Frome A, Patt YZ, El-Serag HB: Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002, 35:266–269.

    Article  PubMed  Google Scholar 

  29. Dyer Z, Peltekian K, van Zanten SV: Review article: the changing epidemiology of hepatocellular carcinoma in Canada. Aliment Pharmacol Ther 2005, 22:17–22.

    Article  PubMed  CAS  Google Scholar 

  30. el-Saadany S, Tepper M, Mao Y, et al.: An epidemiologic study of hepatocellular carcinoma in Canada. Can J Public Health 2002, 93:443–446.

    Google Scholar 

  31. Goodgame B, Shaheen NJ, Galanko J, El-Serag HB: The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol 2003, 98:2535–2542.

    Article  PubMed  Google Scholar 

  32. Kamitsukasa H, Harada H, Tanaka H, et al.: Late liver-related mortality from complications of transfusion-acquired hepatitis C. Hepatology 2005, 41:819–825.

    Article  PubMed  Google Scholar 

  33. Akuta N, Suzuki F, Suzuki Y, et al.: Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival. Scand J Gastroenterol 2005, 40:688–696.

    PubMed  CAS  Google Scholar 

  34. Davila JA, Morgan RO, Shaib Y, et al.: Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004, 127:1372–1380. A complete treatise of the increasing incidence of HCC in the U.S.

    Article  PubMed  Google Scholar 

  35. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002, 62:8–17.

    Article  PubMed  Google Scholar 

  36. Raptis I, Koskinas J, Emmanouil T, Hadziyannis S: Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations. J Viral Hepat 2003, 10:450–454.

    Article  PubMed  CAS  Google Scholar 

  37. Tanaka Y, Hanada K, Mizokami M, et al.: Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002, 99:15584–15589. A fascinating molecular clock extrapolation of HCV evolution and es timation of when HCV entered into the Japanese and U.S. populations and when the virus spread exploded.

    Article  PubMed  CAS  Google Scholar 

  38. Mizokami M, Tanaka Y: Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan. Cancer Chemother Pharmacol 2004, 54:S83-S86.

    PubMed  CAS  Google Scholar 

  39. Kiyosawa K, Umemura T, Ichijo T, et al.: Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004, 127:S17-S26. A very good overview of the changing trends of HCC in the Japanese population.

    Article  PubMed  Google Scholar 

  40. Imazeki F, Yokosuka O, Fukai K, et al.: Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic Hepatitis C. Liver Int 2005, 25:772–778.

    Article  PubMed  Google Scholar 

  41. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS: The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000, 31:777–782.

    Article  PubMed  CAS  Google Scholar 

  42. Wong JB, McQuillan GM, McHutchison JG, Poynard T: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Publi c Health 2000, 90:1562–1569.

    CAS  Google Scholar 

  43. La Vecchia C, Negri E, Pelucchi C: The rise and fall in primary liver cancer mortality in Italy. Dig Liver Dis 2002, 34:169–171.

    Article  PubMed  CAS  Google Scholar 

  44. Sypsa V, Touloumi G, Tassopoulos NC, et al.: Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. J Viral Hepat 2004, 11:366–374.

    Article  PubMed  CAS  Google Scholar 

  45. Nguyen MH, Whittemore AS, Garcia RT, et al.: Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol 2004, 2:820–824.

    Article  PubMed  Google Scholar 

  46. Di Bisceglie AM, Lyra AC, Schwartz M, et al.: Hepatitis Crelated hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003, 98:2060–2063.

    Article  PubMed  Google Scholar 

  47. Peters MG, Terrault NA: Alcohol use and hepatitis C. Hepatology 2002, 36:S220-S225.

    Article  PubMed  Google Scholar 

  48. Donato F, Boffetta P, Puoti M: A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998, 75:347–354.

    Article  PubMed  CAS  Google Scholar 

  49. Shi J, Zhu L, Liu S, Xie WF: A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005, 92:607–612.

    Article  PubMed  CAS  Google Scholar 

  50. Kasahara A, Hayashi N, Mochizuki K, et al.: Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology 1998, 27:1394–1402.

    Article  PubMed  CAS  Google Scholar 

  51. Nishiguchi S, Shiomi S, Nakatani S, et al.: Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet 2001, 357:196–197.

    Article  PubMed  CAS  Google Scholar 

  52. Valla DC, Chevallier M, Marcellin P, et al.: Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment. Hepatology 1999, 29:1870–1875.

    Article  PubMed  CAS  Google Scholar 

  53. Camma C, Giunta M, Andreone P, Craxi A: Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 2001, 34:593–602.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Washington, 1959 NE Pacific Street, Mail Stop 356174, 981 95-6 174, Seattle, WA, USA

    Anne M. Larson MD

Authors
  1. Anne M. Larson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larson, A.M. The epidemiology of hepatocellular carcinoma in hcv. Curr hepatitis rep 4, 145–152 (2005). https://doi.org/10.1007/s11901-005-0030-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-005-0030-4

Keywords

Search

Navigation